Cord Blood Cells for Developmental Toxicology and Environmental Health

Dora Il'yasova1, Noreen Kloc1, Alexander Kinev2

  • 1Division of Epidemiology and Biostatistics, School of Public Health, Georgia State University , Atlanta, GA , USA.

Frontiers in Public Health
|December 24, 2015
PubMed

Insights

The Tox21 program advances in vitro toxicology. Using cord blood cells can improve understanding of toxicant effects on fetal development by capturing cellular response variability.

Area of Science:

  • Toxicology
  • Developmental Biology
  • Cellular Biology

Background:

  • The Tox21 program promotes in vitro testing focusing on toxicological mechanisms.
  • Current developmental toxicology methods have limitations in human population relevance.
  • Variability in cellular responses to toxicants is crucial for human relevance.

Purpose of the Study:

  • To explore the application of in vitro toxicology initiatives in developmental toxicology.
  • To address the gap in human relevance by utilizing cord blood cells.
  • To propose using donor-specific cord blood cells for developmental toxicology testing.

Main Methods:

  • Review of current developmental toxicology approaches.
  • Discussion of using umbilical cord blood cells as a non-invasive source.
  • Proposal for extending toxicological testing to human fetal/newborn cell collections.

Main Results:

  • Identified a gap in the human relevance of current developmental toxicology methods.
  • Highlighted umbilical cord blood as a valuable, non-invasive source of fetal/newborn cells.
  • Proposed a novel approach to capture cellular response variability in toxicological testing.

Conclusions:

  • Umbilical cord blood cells offer a promising avenue for improving developmental toxicology.
  • Testing with donor-specific cells can better reflect human variability in toxicological responses.
  • This approach can enhance understanding of toxicant effects during vulnerable developmental stages.

Related Concept Videos

Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
133
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
11.4K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.4K